Evidence map›Paper›PMID 41607587›Full record

ArticleJCEM case reports2026

Pseudopheochromocytoma With Catecholamine Excess and End-organ Damage: A 30-year Course Treated With Escitalopram.

Ayli S Anvaripour, Leor Needleman, Brian Brady, Justin P Annes

Abstract readCase Reports
In one paragraph

Article in JCEM case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ayli S AnvaripourIndiana University School of Medicine, Indianapolis, IN 46202, USA.ORCID https://orcid.org/0009-0005-5984-8414
Leor NeedlemanDepartment of Medicine, Division of Endocrinology, Gerontology and Metabolism and Endocrine Oncology, Stanford University, Stanford, CA 94305, USA.ORCID https://orcid.org/0009-0006-5637-5591
Brian BradyDepartment of Medicine, Division of Nephrology, Stanford University School of Medicine, Stanord, CA 94305, USA.
Justin P AnnesDepartment of Medicine, Division of Endocrinology, Gerontology and Metabolism and Endocrine Oncology, Stanford University, Stanford, CA 94305, USA.ORCID https://orcid.org/0000-0001-8431-3589

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pseudopheochromocytoma is a disorder characterized by paroxysmal hypertension and variably elevated catecholamine metabolite levels. Pseudopheochromocytoma clinically mimics pheochromocytoma but differs in etiology. While pheochromocytoma is a catecholamine-secreting neuroendocrine tumor, pseudopheochromocytoma is a syndrome linked to a history of emotional stressors and is believed to stem from autonomic nervous system dysregulation. We present the case of a 70-year-old female patient experiencing episodic hypertensive crises for 3 decades. The patient was referred to endocrine oncology for evaluation of a possible pheochromocytoma due to her long-standing history of symptomatic hypertension and elevated catecholamine metabolites. Anatomic and functional imaging, including computed tomography scans of the abdomen and pelvis and a

Indexed as

catecholamine excessparoxysmal hypertensionPseudopheochromocytomaserotonin reuptake inhibitor

Identifiers

PMID41607587
PMCPMC12839531

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.